WO2004064109A3 - Water soluble metal and semiconductor nanoparticle complexes - Google Patents

Water soluble metal and semiconductor nanoparticle complexes Download PDF

Info

Publication number
WO2004064109A3
WO2004064109A3 PCT/US2003/024896 US0324896W WO2004064109A3 WO 2004064109 A3 WO2004064109 A3 WO 2004064109A3 US 0324896 W US0324896 W US 0324896W WO 2004064109 A3 WO2004064109 A3 WO 2004064109A3
Authority
WO
WIPO (PCT)
Prior art keywords
hydrophobic
water soluble
atoms
micelle
soluble metal
Prior art date
Application number
PCT/US2003/024896
Other languages
French (fr)
Other versions
WO2004064109A2 (en
Inventor
Benoit Dubertret
Vincent Noireaux
Albert Libchaber
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Priority to EP03815180.9A priority Critical patent/EP1579506B1/en
Priority to AU2003303717A priority patent/AU2003303717A1/en
Priority to CA2495306A priority patent/CA2495306C/en
Publication of WO2004064109A2 publication Critical patent/WO2004064109A2/en
Publication of WO2004064109A3 publication Critical patent/WO2004064109A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y25/00—Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
    • H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
    • H01F1/0054—Coated nanoparticles, e.g. nanoparticles coated with organic surfactant
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
    • H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
    • H01F1/0063—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use in a non-magnetic matrix, e.g. granular solids
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/01—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials
    • H01F1/03—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity
    • H01F1/12—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials
    • H01F1/34—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites
    • H01F1/36—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites in the form of particles
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/01—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials
    • H01F1/03—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity
    • H01F1/12—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials
    • H01F1/34—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites
    • H01F1/36—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites in the form of particles
    • H01F1/37—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites in the form of particles in a bonding agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989—Microcapsule with solid core [includes liposome]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated

Abstract

The invention provides a water soluble complex comprising an inner core of a metal or semi-conductor nanoparticle. The nanoparticle is coated with a hydrophobic ligand, which is encapsulated in a micelle. In an aqueous medium, the micelle comprises a hydrophilic shell and a hydrophobic core, the hydrophilic shell comprising a plurality of hydrophilic moieties, the hydrophobic core comprising a plurality of hydrophobic moieties, each hydrophobic moiety comprising at least one chain, each chain comprising a minimum of 8 atoms; wherein the total number of atoms in all chains for each moiety comprises at least 24 atoms. The micelle has a minimum average diameter of approximately 5 nm and a maximum average diameter of approximately 45 nm.
PCT/US2003/024896 2002-08-15 2003-08-07 Water soluble metal and semiconductor nanoparticle complexes WO2004064109A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP03815180.9A EP1579506B1 (en) 2002-08-15 2003-08-07 Water soluble metal and semiconductor nanoparticle complexes and method for determining the progeny of target cells
AU2003303717A AU2003303717A1 (en) 2002-08-15 2003-08-07 Water soluble metal and semiconductor nanoparticle complexes
CA2495306A CA2495306C (en) 2002-08-15 2003-08-07 Water soluble metal and semiconductor nanoparticle complexes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/219,440 US7939170B2 (en) 2002-08-15 2002-08-15 Water soluble metal and semiconductor nanoparticle complexes
US10/219,440 2002-08-15

Publications (2)

Publication Number Publication Date
WO2004064109A2 WO2004064109A2 (en) 2004-07-29
WO2004064109A3 true WO2004064109A3 (en) 2007-12-06

Family

ID=31714743

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/024896 WO2004064109A2 (en) 2002-08-15 2003-08-07 Water soluble metal and semiconductor nanoparticle complexes

Country Status (5)

Country Link
US (2) US7939170B2 (en)
EP (2) EP1579506B1 (en)
AU (1) AU2003303717A1 (en)
CA (1) CA2495306C (en)
WO (1) WO2004064109A2 (en)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607829B1 (en) * 1997-11-13 2003-08-19 Massachusetts Institute Of Technology Tellurium-containing nanocrystalline materials
US6207392B1 (en) * 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US6956084B2 (en) * 2001-10-04 2005-10-18 Bridgestone Corporation Nano-particle preparation and applications
AU2003303090A1 (en) * 2002-08-16 2004-08-13 University Of Massachusetts Pyridine and related ligand compounds, functionalized nanoparticulate composites and methods of preparation
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
KR101108439B1 (en) 2002-10-25 2012-01-31 포믹스 리미티드 Cosmetic and pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
JP4683928B2 (en) * 2002-12-18 2011-05-18 株式会社ブリヂストン Clay exfoliation method, composition obtained from the method, and modified rubber containing the composition
US20040252488A1 (en) * 2003-04-01 2004-12-16 Innovalight Light-emitting ceiling tile
US7279832B2 (en) * 2003-04-01 2007-10-09 Innovalight, Inc. Phosphor materials and illumination devices made therefrom
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
AU2004261063A1 (en) * 2003-08-04 2005-02-10 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
US7846412B2 (en) * 2003-12-22 2010-12-07 Emory University Bioconjugated nanostructures, methods of fabrication thereof, and methods of use thereof
US7205370B2 (en) * 2004-01-12 2007-04-17 Bridgestone Corporation Polymeric nano-particles of flower-like structure and applications
US8329501B1 (en) 2004-02-19 2012-12-11 Nanosolar, Inc. High-throughput printing of semiconductor precursor layer from inter-metallic microflake particles
US8623448B2 (en) * 2004-02-19 2014-01-07 Nanosolar, Inc. High-throughput printing of semiconductor precursor layer from chalcogenide microflake particles
US8309163B2 (en) * 2004-02-19 2012-11-13 Nanosolar, Inc. High-throughput printing of semiconductor precursor layer by use of chalcogen-containing vapor and inter-metallic material
US8846141B1 (en) 2004-02-19 2014-09-30 Aeris Capital Sustainable Ip Ltd. High-throughput printing of semiconductor precursor layer from microflake particles
US8642455B2 (en) * 2004-02-19 2014-02-04 Matthew R. Robinson High-throughput printing of semiconductor precursor layer from nanoflake particles
US7306823B2 (en) * 2004-09-18 2007-12-11 Nanosolar, Inc. Coated nanoparticles and quantum dots for solution-based fabrication of photovoltaic cells
US8372734B2 (en) * 2004-02-19 2013-02-12 Nanosolar, Inc High-throughput printing of semiconductor precursor layer from chalcogenide nanoflake particles
CN101031287A (en) * 2004-03-02 2007-09-05 麻省理工学院 Nanocell drug delivery system
US7718737B2 (en) 2004-03-02 2010-05-18 Bridgestone Corporation Rubber composition containing functionalized polymer nanoparticles
US20070053845A1 (en) * 2004-03-02 2007-03-08 Shiladitya Sengupta Nanocell drug delivery system
US8063142B2 (en) 2004-03-02 2011-11-22 Bridgestone Corporation Method of making nano-particles of selected size distribution
US20050220714A1 (en) * 2004-04-01 2005-10-06 Susan Kauzlarich Agents for use in magnetic resonance and optical imaging
US20050228074A1 (en) * 2004-04-05 2005-10-13 Bridgestone Corporation Amphiphilic polymer micelles and use thereof
CA2563619A1 (en) * 2004-04-20 2005-11-03 Emory University Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
US20050282956A1 (en) * 2004-06-21 2005-12-22 Xiaorong Wang Reversible polymer/metal nano-composites and method for manufacturing same
US7998554B2 (en) * 2004-07-06 2011-08-16 Bridgestone Corporation Hydrophobic surfaces with nanoparticles
US7750352B2 (en) * 2004-08-10 2010-07-06 Pinion Technologies, Inc. Light strips for lighting and backlighting applications
KR100604976B1 (en) * 2004-09-03 2006-07-28 학교법인연세대학교 Water-Soluble Nanoparticles Stabilized with Multi-Functional Group Ligands
US7288134B2 (en) * 2004-09-10 2007-10-30 International Business Machines Corporation Dumbbell-like nanoparticles and a process of forming the same
JP2006124262A (en) * 2004-11-01 2006-05-18 Dainippon Printing Co Ltd InSb NANOPARTICLE
US8097742B2 (en) * 2005-01-20 2012-01-17 Agency For Science, Technology And Research Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling
US7572855B2 (en) * 2005-01-28 2009-08-11 Bridgestone Corporation Nano-composite and compositions manufactured thereof
US7579398B2 (en) * 2005-02-02 2009-08-25 Bridgestone Corporation Nano-composite and compositions therefrom
US7659342B2 (en) * 2005-02-03 2010-02-09 Bridgestone Corporation Polymer nano-particle with polar core and method for manufacturing same
WO2006099445A2 (en) * 2005-03-14 2006-09-21 Massachusetts Institute Of Technology Nanocells for diagnosis and treatment of diseases and disorders
KR100626767B1 (en) * 2005-07-07 2006-09-25 한국과학기술연구원 Chain-end functionalized poly(ethylene oxide) and method for the preparation of nano-sized transition metals and metal salts using the same
JP2007079857A (en) * 2005-09-13 2007-03-29 Canon Inc Server apparatus, client apparatuses and those control methods, computer program, storage medium
EP2308513A3 (en) * 2005-11-16 2011-11-23 Signalomics GmbH Fluorescent nanoparticles
ES2627998T3 (en) * 2005-11-16 2017-08-01 Exchange Imaging Technologies Gmbh Fluorescent nanoparticles
CN101313222A (en) * 2005-11-22 2008-11-26 皇家飞利浦电子股份有限公司 Luminescent particle and method of detecting a biological entity using a luminescent particle
US7538159B2 (en) * 2005-12-16 2009-05-26 Bridgestone Corporation Nanoparticles with controlled architecture and method thereof
US9061900B2 (en) * 2005-12-16 2015-06-23 Bridgestone Corporation Combined use of liquid polymer and polymeric nanoparticles for rubber applications
US8288473B2 (en) 2005-12-19 2012-10-16 Bridgestone Corporation Disk-like nanoparticles
US7884160B2 (en) 2005-12-19 2011-02-08 Bridgestone Corporation Non-spherical nanoparticles made from living triblock polymer chains
US8697775B2 (en) * 2005-12-20 2014-04-15 Bridgestone Corporation Vulcanizable nanoparticles having a core with a high glass transition temperature
US8877250B2 (en) * 2005-12-20 2014-11-04 Bridgestone Corporation Hollow nano-particles and method thereof
US8303931B2 (en) 2006-02-17 2012-11-06 Topass Gmbh Multimodal imaging using a three compartment polymer nanoparticle with cell specificity
WO2007143076A2 (en) * 2006-05-31 2007-12-13 Agency For Science, Technology And Research Nanoparticles and coated nanoparticles
US20080008654A1 (en) * 2006-07-07 2008-01-10 Boston Scientific Scimed, Inc. Medical devices having a temporary radiopaque coating
EP2040752A2 (en) * 2006-07-10 2009-04-01 Philips Intellectual Property & Standards GmbH Core-shell nanoparticles for thearapy and imaging purposes
EP3495322A1 (en) 2006-07-28 2019-06-12 Bridgestone Corporation Polymeric core-shell nanoparticles with interphase region
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US7597959B2 (en) * 2006-12-19 2009-10-06 Bridgestone Corporation Core-shell fluorescent nanoparticles
US7649049B2 (en) * 2006-12-20 2010-01-19 Bridgestone Corporation Rubber composition containing a polymer nanoparticle
US8343627B2 (en) * 2007-02-20 2013-01-01 Research Foundation Of State University Of New York Core-shell nanoparticles with multiple cores and a method for fabricating them
US8444280B2 (en) * 2007-04-25 2013-05-21 Universite Laval Magnetically deformable ferrofluids and mirrors
US7829624B2 (en) * 2007-06-29 2010-11-09 Bridgestone Corporation One-pot synthesis of nanoparticles and liquid polymer for rubber applications
US8784846B2 (en) * 2007-07-30 2014-07-22 Loma Linda University Medical Center Systems and methods for particle radiation enhanced delivery of therapy
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9206233B2 (en) * 2007-10-19 2015-12-08 University of Pittsburgh—of the Commonwealth System of Higher Education Templates for controlling synthesis of nanoparticles into discrete assemblies
US9943490B2 (en) * 2007-11-05 2018-04-17 The Trustees Of Princeton University Composite flash-precipitated nanoparticles
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US7785998B2 (en) * 2008-02-21 2010-08-31 Micron Technology, Inc. Methods of forming dispersions of nanoparticles, and methods of forming flash memory cells
EP2093192A1 (en) 2008-02-25 2009-08-26 Koninklijke Philips Electronics N.V. Preparation of nanoparticles from metal salts
DK2288336T3 (en) * 2008-04-25 2017-03-13 Univ Northwestern NANOSTRUCTURES SUITABLE FOR COMPLEXATION OF CHOLESTEROL
WO2010008876A2 (en) * 2008-06-24 2010-01-21 The Regents Of The University Of California Method for preparation of micellar hybrid nanoparticles for therapeutic and diagnostic applications and compositions thereof
EP2370349B1 (en) 2008-12-31 2014-10-29 Bridgestone Corporation Core-first nanoparticle formation process, nanoparticle, and composition
GB0903448D0 (en) 2009-03-02 2009-04-08 Ct Angewandte Nanotech Can A method for the manufacture of nanoparticle complexes and triblock polymer ligands and products thereof
US9062144B2 (en) 2009-04-03 2015-06-23 Bridgestone Corporation Hairy polymeric nanoparticles with first and second shell block polymer arms
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US20110207232A1 (en) * 2009-05-13 2011-08-25 University Of Utah Research Foundation Water soluble ph responsive fluorescent nanoparticles
JP5158375B2 (en) * 2009-07-27 2013-03-06 シャープ株式会社 Semiconductor nanoparticle phosphor
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
GB0916699D0 (en) 2009-09-23 2009-11-04 Nanoco Technologies Ltd Semiconductor nanoparticle-based materials
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
EP2499677B1 (en) * 2009-11-10 2022-03-30 Immunolight, LLC Up coversion system for production of light for treatment of a cell proliferation related disorder
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
US20110172364A1 (en) * 2009-12-29 2011-07-14 Chen Yaohong Charged Nanoparticles And Method Of Controlling Charge
US9115222B2 (en) 2009-12-29 2015-08-25 Bridgestone Corporation Well defined, highly crosslinked nanoparticles and method for making same
US20130034599A1 (en) 2010-01-19 2013-02-07 Northwestern University Synthetic nanostructures including nucleic acids and/or other entities
GB201005601D0 (en) 2010-04-01 2010-05-19 Nanoco Technologies Ltd Ecapsulated nanoparticles
GB201010831D0 (en) 2010-06-28 2010-08-11 Ct Angewandte Nanotech Can A micellular combination comprising a nanoparticle and a plurality of surfmer ligands
US9121065B2 (en) 2010-08-09 2015-09-01 The Trustees Of The University Of Pennsylvania Nanoparticle-oligonucleotide hybrid structures and methods of use thereof
US8771555B2 (en) 2011-05-06 2014-07-08 Neo Solar Power Corp. Ink composition
WO2013106100A1 (en) 2011-09-27 2013-07-18 The Ohio State University Research Foundation Methods for producing nanoparticles and using same
US9428604B1 (en) 2011-12-30 2016-08-30 Bridgestone Corporation Nanoparticle fillers and methods of mixing into elastomers
US9474810B2 (en) 2012-03-02 2016-10-25 General Electric Company Superparamagnetic nanoparticles with PEG substituted α-hydroxy phosphonate shells
WO2014047649A1 (en) 2012-09-24 2014-03-27 The Regents Of The University Of California Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy
US20160145679A1 (en) * 2013-03-01 2016-05-26 Arizona Board Of Regents On Behalf Of Arizona State University Oligonucleotide functionalized quantum dots
US20160058702A1 (en) * 2014-08-29 2016-03-03 The Regents Of The University Of Michigan Cleavable polymeric micelles
US10209258B2 (en) * 2015-08-24 2019-02-19 The Board Of Trustees Of The University Of Illinois Lipoprotein nanoplatelets: fluorescent, zwitterionic probes for molecular and cellular imaging
MX2020012139A (en) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Compositions and methods for treating rosacea and acne.
CN112133553B (en) * 2020-10-30 2021-12-21 福州大学 Continuous preparation method of water-based magnetofluid

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5277913A (en) * 1991-09-09 1994-01-11 Thompson David H Liposomal delivery system with photoactivatable triggered release
US5817856A (en) * 1995-12-11 1998-10-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Radiation-protective phospholipid and method
US6251303B1 (en) * 1998-09-18 2001-06-26 Massachusetts Institute Of Technology Water-soluble fluorescent nanocrystals

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940004269B1 (en) 1991-03-13 1994-05-19 금성일렉트론 주식회사 Mos fet and manufacturing method thereof
US5505928A (en) 1991-11-22 1996-04-09 The Regents Of University Of California Preparation of III-V semiconductor nanocrystals
US5262357A (en) 1991-11-22 1993-11-16 The Regents Of The University Of California Low temperature thin films formed from nanocrystal precursors
JPH07502479A (en) 1991-11-22 1995-03-16 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Semiconductor microcrystals covalently bonded to solid inorganic surfaces using self-assembled monolayers
US5336507A (en) * 1992-12-11 1994-08-09 Sterling Winthrop Inc. Use of charged phospholipids to reduce nanoparticle aggregation
JP2000504374A (en) 1995-12-28 2000-04-11 アール． ヒース，ジェイムズ Monodisperse microcrystals of organically functionalized metals
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6322901B1 (en) * 1997-11-13 2001-11-27 Massachusetts Institute Of Technology Highly luminescent color-selective nano-crystalline materials
US5990479A (en) * 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6207392B1 (en) * 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6036886A (en) * 1998-07-29 2000-03-14 Nanocrystals Technology L.P. Microemulsion method for producing activated metal oxide nanocrystals
US6326144B1 (en) * 1998-09-18 2001-12-04 Massachusetts Institute Of Technology Biological applications of quantum dots
US6306610B1 (en) * 1998-09-18 2001-10-23 Massachusetts Institute Of Technology Biological applications of quantum dots
EP1179185B1 (en) * 1999-05-07 2009-08-12 Life Technologies Corporation A method of detecting an analyte using semiconductor nanocrystals
US6242188B1 (en) * 1999-07-30 2001-06-05 Applied Gene Technologies, Inc. Sample processing to release nucleic acids for direct detection
FR2800636A1 (en) 1999-11-05 2001-05-11 Bio Merieux COMPOSITE PARTICLES, DERIVATIVE CONJUGATES, PROCESS FOR THEIR PREPARATION AND USES
FR2800635B1 (en) 1999-11-05 2002-07-26 Bio Merieux COMPOSITE NANOSPHERES, DERIVATIVE CONJUGATES, METHOD OF PREPARATION AND USES THEREOF

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5277913A (en) * 1991-09-09 1994-01-11 Thompson David H Liposomal delivery system with photoactivatable triggered release
US5817856A (en) * 1995-12-11 1998-10-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Radiation-protective phospholipid and method
US6251303B1 (en) * 1998-09-18 2001-06-26 Massachusetts Institute Of Technology Water-soluble fluorescent nanocrystals

Also Published As

Publication number Publication date
EP2469285A1 (en) 2012-06-27
AU2003303717A8 (en) 2008-02-28
EP1579506A2 (en) 2005-09-28
EP1579506B1 (en) 2013-05-15
EP1579506A4 (en) 2009-06-17
US20040033345A1 (en) 2004-02-19
CA2495306C (en) 2012-12-11
US20080193762A1 (en) 2008-08-14
US7951453B2 (en) 2011-05-31
WO2004064109A2 (en) 2004-07-29
CA2495306A1 (en) 2004-07-29
AU2003303717A1 (en) 2004-08-10
US7939170B2 (en) 2011-05-10

Similar Documents

Publication Publication Date Title
WO2004064109A3 (en) Water soluble metal and semiconductor nanoparticle complexes
EP1593730A4 (en) Semiconductor nanoparticle and method for producing same
WO2002066019A3 (en) Cancer treatment
WO2002074238A3 (en) Water soluble and palatable complexes
WO2003033025A3 (en) Cyclodextrin complexes
WO2002047162A3 (en) Microelectronic package having an integrated heat sink and build-up layers
AU6184101A (en) Coated nanoparticles
ATE266201T1 (en) COMPOSITE DNANOPARTICLES AND THEIR CONJUGATES WITH BIOMOLECULES
WO2002103487A3 (en) Method for structuring a transaction
AR019705A1 (en) AN ANTIMICROBIC COMPOSITION FOR HAIR TREATMENT
CA2328998A1 (en) Method of fabricating a banded prolonged release active agent dosage form
EP1261033A3 (en) On chip inductive structure
WO2001034137A3 (en) Oncolytic combinations for the treatment of cancer
WO2023107765A3 (en) Ultrasound-responsive aqueous two-phase microcapsule design for on-demand pulsatile drug release
USD454063S1 (en) Package for liquid foodstuffs
WO1999036354A3 (en) Method of producing substantially spherical lyogels in water insoluble silylating agents
CA2355776A1 (en) Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
USD450428S1 (en) Surface pattern for a footwear sole
ATE310905T1 (en) INVERSE GEAR ROTOR SET
WO2001034198A3 (en) Oncolytic combinations for the treatment of cancer
CA2342060A1 (en) Limited slip differential
WO2001031374A8 (en) Silicon nanoparticle stimulated emission devices
EP1302810A3 (en) Photosemiconductor device and method for fabricating the same
WO2003003122A3 (en) Method of measuring critical dimension and overlay in single step
EP1037342A3 (en) Semiconductor laser device and fabrication method thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2495306

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2003815180

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003815180

Country of ref document: EP

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP